The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is launching a new project on the microbiome funded by Bayer, BMS, Eagle Genomics, Pfizer, Roche and Takeda – which aims to incorporate microbiome data into the drug development pipeline by gathering all existing microbiome data to create a global standardized ‘atlas’ that scientists can refer to when choosing new drug candidates.   The information on the microbiome is vas...